Dr. Dang received her Ph.D. in Immunology from University of Surrey, United Kingdom in 1996. She completed her postdoctoral studies in the Reproductive Immunologic Laboratory at Swedish Medical Center, Denver, Colorado in 2000. Dr. Dang is an expert T cell biologist. She has extensive experience in projects related to T cell therapy in both academia and industry. Within the Tumor Vaccine Group she is involved with the development of adoptive T cell immunotherapy for the treatment of metastatic breast cancer, including establishing ex vivo T cell expansion as a GMP technique.